Today: 11 februari 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-matrice-30t-pl- Page 275

Oriental Rise’s Wild Tea Ride: From $56 High to Penny Stock – 2025’s Shocking Ups and Downs Revealed

Oriental Rise’s Wild Tea Ride: From $56 High to Penny Stock – 2025’s Shocking Ups and Downs Revealed

Oriental Rise Holdings (NASDAQ: ORIS) closed at $0.19 on Nov 4, 2025, down 95% from its IPO, after a year of extreme volatility and a July share offering that triggered a 66% one-day crash. The China-based tea company reported 2024 revenue of $15 million (–38% YoY) and net income of $2.09 million (–82%), despite holding $43 million in cash and no debt. ORIS risks Nasdaq delisting unless it regains compliance by Dec 29.
4 november 2025
·
Pixel 10 vs. iPhone 17 – 2025 Flagship Showdown Leaks Reveal Shocking Upgrades

Pixel 10 Price Earthquake: Google’s Entire Lineup Just Dropped—Here’s What’s Real, What’s Hype, and What It Means for Your Wallet (and Alphabet’s Stock)

Google’s Pixel 10 lineup is discounted through Nov 9, with the Pixel 10 Pro Fold at $1,499—its first major price cut since launch. Deals are live at Amazon, Best Buy, and Google Store. The Pixel 10 series adds Qi2 magnetic charging; the Fold is the first IP68-rated foldable. Alphabet’s Q3 2025 revenue reached $102.3 billion, up 16% year-over-year.
5 november 2025
·
Arista Networks Stock Skyrockets 40% YTD on AI Boom – But Q3 Guidance Triggers Pullback

Arista Networks Stock Skyrockets 40% YTD on AI Boom – But Q3 Guidance Triggers Pullback

Arista Networks shares surged nearly 40% year-to-date in 2025, far outpacing the S&P 500. The stock hit a record high in late October before dropping about 12% after Q3 earnings, as guidance signaled flat Q4 revenue and lower margins. Q3 revenue rose 27.5% to $2.31 billion, beating estimates. Most analysts remain positive, but some cite high valuation and slowing growth.
5 november 2025
·
Roche’s $3.5B Bet on 89bio (ETNB) – Stock Soars to New Highs as NASH Breakthrough Looms

Roche’s $3.5B Bet on 89bio (ETNB) – Stock Soars to New Highs as NASH Breakthrough Looms

Roche completed its $3.5 billion acquisition of 89bio on Oct. 29, 2025, paying $14.50 per share in cash plus up to $6.00 per share in milestones. ETNB stock hit a 52-week high of $15.06 after the deal, reflecting a 52% premium. 89bio’s lead drug, pegozafermin, is in Phase 3 trials for MASH and SHTG. The company remains pre-revenue, reporting a $149 million net loss over the past year.
5 november 2025
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Technologies’ shares have surged over 150% in 2025, hitting an all-time high near $207 before a post-earnings dip to the upper-$180s. Q3 revenue soared 63% to $1.18 billion, with U.S. commercial sales more than doubling. The company posted $0.18 GAAP EPS and $540 million in free cash flow. Michael Burry disclosed a large bearish bet, while Jim Cramer raised his price target to $200.
5 november 2025
···
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense shares fell to the mid-$70s after Q3 revenue beat estimates but Q4 guidance missed forecasts, cutting market cap to $13 billion. The company announced a $356.3 million cash acquisition of Israel’s Orbit Technologies and raised 2025 revenue guidance. Year-to-date, the stock is up over 300%, hitting a 21-year high in October. Analyst consensus is “Moderate Buy” with targets ranging from $77 to $125.
5 november 2025
···
Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

Orkla India IPO Listing Today: Shares List at 2.75–3% Premium, Slip Up to 7% Intraday; GMP, Subscription & Analyst Views (Nov 6, 2025)

Orkla India shares opened at ₹750.10 on NSE and ₹751.50 on BSE, just above the ₹730 IPO price, but soon fell below it, dropping as much as 7% intraday. The debut missed grey-market expectations, which had pointed to a stronger start. The IPO, a ₹1,667.54 crore offer for sale, was subscribed nearly 49 times overall. Early-session market cap stood at about ₹10,295 crore.
6 november 2025
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) today: Court denies bid to block Novo–Metsera deal; Pfizer preps sweeter offer and leans on higher 2025 EPS outlook

A Delaware court denied Pfizer’s request to block Metsera from ending their merger deal in favor of Novo Nordisk’s higher bid. Pfizer plans to raise its offer after Novo’s proposal reached up to $10 billion. FTC staff warned Novo’s bid structure could violate pre-merger rules. Pfizer shares traded near $24.61 midday Thursday.
6 november 2025
··
DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash shares fell about 9% premarket after the company said it will boost 2026 spending by several hundred million dollars to accelerate a new global tech platform, overshadowing strong Q3 results. Revenue rose 27% to $3.45 billion and total orders climbed 21%, but EPS of $0.55 missed estimates. The Deliveroo acquisition closed Oct. 2. DoorDash’s $5 billion buyback remains unused.
6 november 2025
·
AMD Stock Skyrockets on AI Mega-Deals & Quantum Breakthrough – Is $300 Next?

AMD Stock Today (Nov 7, 2025): Shares Close at $233.54 After Thursday’s Rout; CICC Upgrade, Heavy Options Activity, and Analyst Day Looming

AMD shares closed down 1.75% at $233.54 on Nov. 7 after a 7.27% drop the previous day, as semiconductor stocks slumped with the Nasdaq. Trading volume and options activity surged, with 1.16 million contracts changing hands. CICC upgraded AMD to Outperform after the close. The company beat Q3 estimates earlier in the week and will hold its Financial Analyst Day on Nov. 11.
8 november 2025
Samsung Galaxy S26 Leak Explosion: Massive Camera Upgrades, Thinner Designs & a Shocking S Pen Twist

‘Landfall’ spyware abused Samsung zero‑day (CVE‑2025‑21042) to hack Galaxy phones for months — patched in April: What happened and how to stay safe

Researchers have identified a commercial Android spyware campaign, Landfall, that exploited a zero-day flaw in Samsung Galaxy phones and targeted users in the Middle East for nearly a year. The spyware used malicious image files to compromise devices and steal data. Samsung patched the vulnerability in April 2025. Targets included Galaxy S22, S23, S24, and Z Fold 4/Flip 4 running Android 13–15.
8 november 2025
Samsung Confirms 10.7Gbps LPDDR6 and 14.8GB/s Gen5 PM9E1 SSD Ahead of CES 2026

Samsung Confirms 10.7Gbps LPDDR6 and 14.8GB/s Gen5 PM9E1 SSD Ahead of CES 2026

Samsung will debut 10.7Gbps LPDDR6 DRAM and a compact Gen5 PM9E1 SSD with up to 14.8GB/s read and 13.4GB/s write speeds at CES 2026 in Las Vegas. The 12nm LPDDR6 offers about 21% better energy efficiency over previous models. The PM9E1 SSD features a 42mm M.2 form factor, “Presto” controller, V8 TLC V-NAND, and up to 4TB capacity. Both products are CES Innovation Awards honorees.
8 november 2025
··
Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Pfizer (PFE) Clinches $10 Billion Metsera Deal as Novo Nordisk Exits—What It Means for the Obesity Drug Race (Nov. 8, 2025)

Pfizer secured a deal to acquire obesity-drug developer Metsera for up to $10 billion after Novo Nordisk withdrew its rival bid, citing FTC antitrust concerns. Metsera shareholders are set to vote Nov. 13 on Pfizer’s offer of $65.60 in cash plus up to $20.65 per share in contingent value rights. Metsera’s board recommended approval. Metsera shares surged nearly 60% during the bidding.
8 november 2025
·
Home Depot Stock Pre-Market Report: Key Catalysts & Forecast for Nov. 3, 2025

Home Depot (HD) Stock: What to Know Before the Market Opens on November 10, 2025

Home Depot will report Q3 earnings on Nov. 18 after Q2 sales rose 4.9% to $45.3 billion and U.S. comps increased 1.4%. The company completed its $5.5 billion SRS Distribution-GMS acquisition in September, expanding its pro contractor reach. Mortgage rates averaged 6.22% last week, while builder confidence improved. October CPI data is due Nov. 13, with housing starts out Nov. 19.
9 november 2025
·
Lenskart IPO Frenzy: Sky-High Valuation Meets Surging Demand – Will Investors See Big Gains?

Lenskart IPO Listing Today: Shares List at a Discount, Fall 11% Intraday, Then Close Above Issue Price — What It Means for Investors (Nov 10, 2025)

Lenskart shares opened below their ₹402 issue price in Mumbai on Monday, dropped as much as 11% to intraday lows near ₹356, then rebounded to close slightly higher at ₹404.55 on the NSE. Early trading implied a market value of about ₹69,000 crore. The debut followed concerns over high valuations and a sharp fall in grey-market premiums despite strong IPO demand.
10 november 2025
·
E. coli Alert: France Recalls Reblochon de Savoie AOP Sold at E.Leclerc, Grand Frais and Fresh — What to Check Now (November 10, 2025)

E. coli Alert: France Recalls Reblochon de Savoie AOP Sold at E.Leclerc, Grand Frais and Fresh — What to Check Now (November 10, 2025)

French authorities recalled two Reblochon de Savoie AOP cheeses for E. coli STEC O26 contamination: E.Leclerc’s “Nos Régions ont du Talent” (lots 5-258, 5-258V) and Masson Reblochon sold at Grand Frais and Fresh (lot 5-258V). Products were sold nationwide between October and November 2025. Consumers are told not to eat the cheese and to return or destroy it for a refund. Recall ends November 21 or 26, depending on retailer.
10 november 2025
1 … 273 274 275 276 277 … 279
Go toTop